Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CXCR
    (2)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

cxcl12 ligand 1

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
CXCL12 ligand 1
T394402045891-59-4
CXCL12 ligand 1 is the initial ligand of the sY12-binding pocket on chemokine CXCL12.
  • $1,520
4-6 weeks
Size
QTY
CXCR4 antagonist 10
T2005683056005-98-9
CXCR4 antagonist 10 is a small-molecule antagonist of the chemokine receptor CXCR4 that inhibits related signaling pathways and cell migration by blocking the binding of CXCR4 to its ligand, CXCL12 (SDF-1). In vitro studies have shown that CXCR4 antagonist 10 can interfere with tumor cell metastasis and immune cell chemotaxis, demonstrating potential value in antitumor and anti-inflammatory research.
  • $1,520
4-6 weeks
Size
QTY
S-Geranylgeranyl-L-glutathione
GGG
T839262364639-42-7
S-Geranylgeranyl-L-glutathione acts as a ligand for the orphan G protein-coupled receptor (GPCR) P2RY8, displaying selective affinity by inducing internalization of P2RY8 in preference to the sphingosine-1-phosphate receptor 2 (S1P2), GPR55, cysteinyl leukotriene receptor 1 (CysLT1 receptor), and the CysLT2 receptor at a concentration of 100 nM. Additionally, at a lower concentration of 10 nM, S-Geranylgeranyl-L-glutathione inhibits the chemokine (C-X-C motif) ligand 12-induced migration of both P2RY8-expressing WEHI-231 B cell lymphoma cells and human tonsil germinal center B cells.
  • $94
35 days
Size
QTY